Stock TMED EGF THERAMED HEALTH CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Financials EGF Theramed Health Corp.

Equities

TMED

CA2684692023

Biotechnology & Medical Research

Delayed Canadian Securities Exchange
Other stock markets
 09:44:18 2024-06-27 EDT 		5-day change 1st Jan Change
0.12 CAD 0.00% Intraday chart for EGF Theramed Health Corp. -7.69% -36.84%
05-23 EGF Theramed Health Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 CI
02-26 EGF Theramed Health Corp. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 CI

Valuation

Fiscal Period: June 2021 2022 2023
Capitalization 1 5.134 0.6474 5.246
Enterprise Value (EV) 1 5.556 1.852 6.574
P/E ratio -2.76 x -0.48 x -8.02 x
Yield - - -
Capitalization / Revenue - - -
EV / Revenue - - -
EV / EBITDA - - -
EV / FCF - -2,976,622 x -29,644,157 x
FCF Yield - -0% -0%
Price to Book 56.1 x -0.63 x -4.59 x
Nbr of stocks (in thousands) 2,054 2,158 10,491
Reference price 2 2.500 0.3000 0.5000
Announcement Date 21-11-01 22-10-28 23-10-30
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Junio 2021 2022 2023
Net sales - - -
EBITDA - - -
EBIT 1 -0.8661 -0.9713 -0.3488
Operating Margin - - -
Earnings before Tax (EBT) 1 -0.7443 -1.364 -0.6435
Net income 1 -0.9735 -1.35 -0.623
Net margin - - -
EPS 2 -0.9069 -0.6266 -0.0624
Free Cash Flow - -0.6222 -0.2218
FCF margin - - -
FCF Conversion (EBITDA) - - -
FCF Conversion (Net income) - - -
Dividend per Share - - -
Announcement Date 21-11-01 22-10-28 23-10-30
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: June 2021 2022 2023
Net Debt 1 0.42 1.2 1.33
Net Cash position 1 - - -
Leverage (Debt/EBITDA) - - -
Free Cash Flow - -0.62 -0.22
ROE (net income / shareholders' equity) - 76.9% 26.7%
ROA (Net income/ Total Assets) - -88.3% -117%
Assets 1 - 1.53 0.5321
Book Value Per Share 2 0.0400 -0.4700 -0.1100
Cash Flow per Share 2 0.3400 0.0100 0
Capex - - -
Capex / Sales - - -
Announcement Date 21-11-01 22-10-28 23-10-30
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
EGF THERAMED HEALTH CORP. Stock EGF Theramed Health Corp.
-36.84% 998K
MODERNA, INC. Stock Moderna, Inc.
+22.33% 46.93B
LONZA GROUP AG Stock Lonza Group AG
+37.63% 39.08B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-8.50% 38.48B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
+30.27% 31.01B
CELLTRION, INC. Stock Celltrion, Inc.
-13.75% 26.14B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+11.23% 25.88B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+35.06% 12.53B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
-6.54% 11.36B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-12.62% 10.65B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. TMED Stock
  4. Financials EGF Theramed Health Corp.